Who owns Orexigen Therapeutics?

Key details on Orexigen Therapeutics (Ticker: OREX)

Who owns Orexigen Therapeutics?

Is OREX a good stock to own? Find out who bought Orexigen Therapeutics, who sold Orexigen Therapeutics (OREX) stock, and who holds a large position in Orexigen Therapeutics.

Fund Name Number of Shares Share Valuation As Of
STATE STREET CORPORATION 11.78M $24.86M Sept. 30, 2015
FMR 11.60M $24.47M Sept. 30, 2015
T. Rowe Price Associates 6.49M $13.70M Sept. 30, 2015
Samlyn Capital 6.16M $13.00M Sept. 30, 2015
Vanguard 6.06M $10.42M Dec. 31, 2015
QVT Financial 5.12M $7.43M Dec. 31, 2011
BlackRock Fund Advisors 4.46M $9.40M Sept. 30, 2015
Franklin Resources 4.32M $9.12M Sept. 30, 2015
Foresite Capital Management II 4.31M $9.09M Sept. 30, 2015
S.A.C. Capital Advisors 4.30M $24.20M Dec. 31, 2013
Millennium Management 3.94M $8.31M Sept. 30, 2015
Credit Suisse AG 3.81M $8.03M Sept. 30, 2015
NEA Management Company 3.71M $6.38M Dec. 31, 2015
Capital Research Global Investors^ 3.62M $28.34M March 31, 2015
MORGAN STANLEY 3.30M $5.71M Dec. 31, 2015
Scale Management 2.88M $22.58M March 31, 2015
Deutsche Bank Aktiengesellschaft 2.88M $6.08M Sept. 30, 2015
Partner Fund Management 2.87M $22.48M March 31, 2015
BlackRock Institutional Trust Company, N.A. 2.81M $5.93M Sept. 30, 2015
FIRST MANHATTAN 2.81M $17.37M June 30, 2014
Renaissance Technologies 2.78M $5.87M Sept. 30, 2015
Farallon Capital Management 2.68M $17.45M March 31, 2014
SUSQUEHANNA INTERNATIONAL 2.53M $10.77M Sept. 30, 2014
RS INVESTMENT MANAGEMENT 2.23M $9.50M Sept. 30, 2014
FIL 2.21M $14.34M March 31, 2014
Meditor 2.10M $12.87M Sept. 30, 2013

Who sold Orexigen Therapeutics?

Fund Name Date Sold Number of Shares Sold Share Valuation
Bank of America Corporation June 30, 2015 2.07M $10.25M